Awarded NIH Grant to Develop Therapies for Alzheimer’s Disease
In Apr 2021, AivoCode was awarded SBIR Phase I grant from National Institute of Aging at NIH for developing therapies for treating Alzheimer’s disease. These therapies are directed to a novel target to reverse vascular deficit as a therapeutic intervention in Alzheimer’s disease.